Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Coburn

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Journal of Parkinson'S Disease|July 5, 2024
A Randomized Controlled Trial of Fecal Microbiota Transplantation for Parkinson's Disease: Getting it right, if not PARFECTMilan Beckers, Bryan Coburn, Lorraine V Kalia, et al.
Microbes and Infection|March 2, 2021
Therapeutic interventions and mechanisms associated with gut microbiota-mediated modulation of immune checkpoint inhibitor responsesMatthew K Wong, Philip Barbulescu, Bryan Coburn, et al.
Infection and Immunity|May 24, 2005
Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitisBryan Coburn, Yuling Li, David Owen, et al.
Journal of Periodontology|May 13, 2026
Transient gingival inflammation is associated with epithelial dysfunction and systemic immune activation beyond clinical improvementOmnia Elebyary, Rachel Liu, Jinny Tsang, et al.
CMAJ Open|April 21, 2018
Regional variability in fecal microbiota transplantation practices: a survey of the Southern Ontario Fecal Microbiota Transplantation MovementSusy S Hota, Salman Surangiwala, Aimee S Paterson, et al.
Microbiome|October 31, 2019
Microbiota analysis optimization for human bronchoalveolar lavage fluidPierre H H Schneeberger, Janice Prescod, Liran Levy, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Antimicrobial susceptibilities of clinical isolates of HACEK organismsBryan Coburn, Baldwin Toye, Prasad Rawte, et al.
Journal of Clinical Microbiology|March 22, 2019
Comparing Patient Risk Factor-, Sequence Type-, and Resistance Locus Identification-Based Approaches for Predicting Antibiotic Resistance in Escherichia coli Bloodstream InfectionsDerek R MacFadden, Roberto G Melano, Bryan Coburn, et al.
Journal of Epidemiology and Global Health|April 30, 2015
Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospitalColin Lee, Sandra A N Walker, Nick Daneman, et al.
Plos One|February 10, 2017
Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programsJosie Hughes, Xi Huo, Lindsey Falk, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Journal of Parkinson'S Disease|July 5, 2024
A Randomized Controlled Trial of Fecal Microbiota Transplantation for Parkinson's Disease: Getting it right, if not PARFECTMilan Beckers, Bryan Coburn, Lorraine V Kalia, et al.
Microbes and Infection|March 2, 2021
Therapeutic interventions and mechanisms associated with gut microbiota-mediated modulation of immune checkpoint inhibitor responsesMatthew K Wong, Philip Barbulescu, Bryan Coburn, et al.
Infection and Immunity|May 24, 2005
Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitisBryan Coburn, Yuling Li, David Owen, et al.
Journal of Periodontology|May 13, 2026
Transient gingival inflammation is associated with epithelial dysfunction and systemic immune activation beyond clinical improvementOmnia Elebyary, Rachel Liu, Jinny Tsang, et al.
CMAJ Open|April 21, 2018
Regional variability in fecal microbiota transplantation practices: a survey of the Southern Ontario Fecal Microbiota Transplantation MovementSusy S Hota, Salman Surangiwala, Aimee S Paterson, et al.
Microbiome|October 31, 2019
Microbiota analysis optimization for human bronchoalveolar lavage fluidPierre H H Schneeberger, Janice Prescod, Liran Levy, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2013
Antimicrobial susceptibilities of clinical isolates of HACEK organismsBryan Coburn, Baldwin Toye, Prasad Rawte, et al.
Journal of Clinical Microbiology|March 22, 2019
Comparing Patient Risk Factor-, Sequence Type-, and Resistance Locus Identification-Based Approaches for Predicting Antibiotic Resistance in Escherichia coli Bloodstream InfectionsDerek R MacFadden, Roberto G Melano, Bryan Coburn, et al.
Journal of Epidemiology and Global Health|April 30, 2015
Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospitalColin Lee, Sandra A N Walker, Nick Daneman, et al.
Plos One|February 10, 2017
Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programsJosie Hughes, Xi Huo, Lindsey Falk, et al.
Pageof 9